课题基金 / 基金详情

CLINICAL TRIAL OF RASAGILINE MESYLATE IN EARLY PARKINSONS DISEASE

CLINICAL TRIAL OF RASAGILINE MESYLATE IN EARLY PARKINSONS DISEASE
甲磺酸雷沙吉兰治疗早期帕金森病的临床试验
批准号：
6469298
负责人：
MICHAEL Jeffrey AMINOFF
金额：
$6.87万
依托单位：
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
依托单位国家：
美国
项目类别：
财政年份：
2000
资助国家：
美国
项目状态：
已结题
起止时间：
2000-12-01 至 2001-11-30
来源：
https://reporter.nih.gov/project-details/6469298
关键词：
Parkinson's disease antiparkinson drugs brain disorder chemotherapy clinical research clinical trial phase I human subject human therapy evaluation

项目成果

MICHAEL Jeffrey AMINOFF的其他基金

相关文献

期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A MULTICENTER, DOUBLE-BLIND, PILOT STUDY OF COQ10 AND GPI 1485 IN SUBJECTS WITH)
MINOCYCLINE AND CREATINE IN SUBJECTS WITH EARLY UNTREATED PARKINSON'S DISEASE
Parkinson's Research: The Organized Genetics Initiative (PROGENI)
Minocycline and Creatine in Subjects With Early Untreated Parkinson's Disease